Agencies face numerous challenges, including the need to keep up with the rapid development of new chemicals and technologies. The complexity of chemical mixtures, limited data on long-term effects, and variability in individual susceptibility pose significant hurdles. Additionally, balancing economic interests with public health protection remains a constant challenge for regulatory agencies.
